LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION April 27, 2009 TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health FROM: John S. O'Brien, Director, Legislative Budget Board IN RE:HB1504 by McClendon (Relating to the normal distribution channel of a prescription drug.), As Introduced No fiscal implication to the State is anticipated. Local Government Impact No fiscal implication to units of local government is anticipated. Source Agencies:515 Board of Pharmacy LBB Staff: JOB, CL, ES
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION
April 27, 2009
TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health FROM: John S. O'Brien, Director, Legislative Budget Board IN RE:HB1504 by McClendon (Relating to the normal distribution channel of a prescription drug.), As Introduced
TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health
FROM: John S. O'Brien, Director, Legislative Budget Board
IN RE: HB1504 by McClendon (Relating to the normal distribution channel of a prescription drug.), As Introduced
Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health
Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health
John S. O'Brien, Director, Legislative Budget Board
John S. O'Brien, Director, Legislative Budget Board
HB1504 by McClendon (Relating to the normal distribution channel of a prescription drug.), As Introduced
HB1504 by McClendon (Relating to the normal distribution channel of a prescription drug.), As Introduced
No fiscal implication to the State is anticipated.
No fiscal implication to the State is anticipated.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies: 515 Board of Pharmacy
515 Board of Pharmacy
LBB Staff: JOB, CL, ES
JOB, CL, ES